Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2010
03/24/2010CN101679441A Compounds for the treatment of hepatitis c
03/24/2010CN101679440A Pyrrolopyrimidine derivatives as jak3 inhibitors
03/24/2010CN101679439A P70 s6激酶抑制剂 P70 s6 kinase inhibitors
03/24/2010CN101679438A Compound for organic electroluminescent device and organic electroluminescent device
03/24/2010CN101679437A cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/24/2010CN101679436A Fused ring heterocycle kinase modulators
03/24/2010CN101679416A Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu
03/24/2010CN101679414A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679412A Purinones and 1h-imidazopyridinones as PKC-theta inhibitors
03/24/2010CN101679409A New compounds
03/24/2010CN101679408A Bicyclic heterocyclic compounds as FGFR inhibitors
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679367A Therapeutic agent for cerebral infarction
03/24/2010CN101679348A 5-pyridinone substituted indazoles
03/24/2010CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease
03/24/2010CN101679275A New compounds 707 and their uses
03/24/2010CN101679245A 3-(2-alkoxy-phenyl)-substituted tetramates
03/24/2010CN101679241A Prolinamide derivatives as NK3 antagonists
03/24/2010CN101678026A 3, 6-disubstituted-imidazo [1, 2-B] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-A] pyrimidines as phosphatidylinositol-3-kinase inhibitors
03/24/2010CN101676288A Iminazole chiral organic micromolecule compound with bicyclo-structure and synthesizing method thereof
03/24/2010CN101676287A 6-(substituted phenoxy)-tetrazolo[5,1-a] phthalazine derivatives as antuepileptics and their pharmaceutically acceptable salts
03/23/2010US7683060 3-[1-(4-Methoxyphenyl)cyclopropyl]-6-phenyl[1,2,4]triazolo[4,3-b][1,2,4]triazine; cancer and other diseases related to the dysregulation of kinase pathways; c-Met inhibitors
03/23/2010US7683056 Pyridine derivatives and their use in the treatment of psychotic disorders
03/23/2010US7682762 Combining liquid phase of a fatty acid and an alcohol solvent and a solid phase of a sodium salt of the fatty acid to induce a phase transfer reaction; heating to form phthalocyanine complexes with metal ions
03/23/2010CA2459928C Photodynamic porphyrin antimicrobial agents
03/18/2010WO2010030983A2 Pyrazole carboxamide inhibitors of factor xa
03/18/2010WO2010030500A1 Aza-benzimidazolone chymase inhibitors
03/18/2010WO2010030224A1 A process for preparing [1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ] -3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino] - 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d] pyrimidin-3-yl] -5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
03/18/2010WO2010029232A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
03/18/2010WO2010028780A2 Preparation and uses of guanidinium-modified porphyrins and phthalocyanines
03/18/2010WO2010028761A1 2-heteroaryl-pyrrolo [3, 4-c]pyrrole derivatives and the use thereof as scd inhibitors
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009156863A3 Substituted tricyclic derivatives against neurodegenerative diseases
03/18/2010WO2009134616A3 Novel inhibitors of hepatitis c virus replication
03/18/2010WO2009131974A8 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
03/18/2010WO2009095923A3 Corroles for neuroprotection and neurorescue
03/18/2010US20100069632 Salts of pyrrolopyrimidinone derivatives and process for preparing the same
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/18/2010US20100069407 CXCR2 inhibitors
03/18/2010US20100069396 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
03/18/2010US20100069395 Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid compounds as protein kinase inhibitors
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069359 Constrained spirocyclic compounds as cgrp receptor antagonists
03/18/2010US20100069357 Pyrimidine compounds, compositions and methods of use
03/18/2010US20100069355 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection
03/18/2010US20100069333 Alpha-helix mimetics and method relating to the treatment of cancer stem cells
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100065123 Electrically conducting porphyrin and porphyrin-fullerene electropolymers
03/18/2010CA2737218A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
03/18/2010CA2736522A1 Aza-benzimidazolone chymase inhibitors
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2735369A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/18/2010CA2734454A1 A process for preparing [1s-[1-alpha,2-alpha,3-beta(1s*, 2r*)5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3h-1,2,3-triazolo [4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to its intermediates
03/17/2010EP2163554A1 Pyrimidodiazepinone derivative
03/17/2010EP2162132A1 Heterocyclic kinase modulators
03/17/2010EP1984373B1 6,7-dihydrobenzimidazo[1 ,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof
03/17/2010EP1981509B1 Pyrazolo[1,5-a]pyrimidine derivatives for use in treatment of Alzheimer's disease and related conditions
03/17/2010EP1786810B1 Ligands for g-protein coupled receptors
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1641423B1 Benzodiazepine cgrp receptor antagonists
03/17/2010CN101675056A Heterocyclic compounds and their use as pesticides
03/17/2010CN101675052A Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h.6h) carbaldehyde derivatives
03/17/2010CN101675051A Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
03/17/2010CN101674834A inhibitors of bruton's tyrosine kinase
03/17/2010CN101671341A Preparation method of iron chlorophyll extract
03/17/2010CN101671340A Carboxyl porphyrin and preparation method thereof
03/17/2010CN101671339A Citric acid alidenafil crystal form B and preparation method and usage thereof
03/17/2010CN101671338A Citric acid alidenafil crystal form D and preparation method and usage thereof
03/17/2010CN101671337A Citric acid aildenafil crystal form A and preparation method and usage thereof
03/17/2010CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/16/2010US7678900 Refined routes to chlorin building blocks
03/16/2010US7678825 Administering 2-[1-(3-Ethoxy-4-methoxyphenyl)2-methylsulfonylethyl]4,5-diaminoisoindoline-1,3-dione or salts to treat Crohn's disease, inflammatory bowel disease, psoriasis, rheumatoid arthritis, spondylitis, osteoarthritis, or ulcerative colitis; tumor necrosis factor and phosphodiesterase inhibitors
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678801 Compounds
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678793 Azolo triazines and pyrimidines
03/16/2010US7678787 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
03/16/2010US7678728 made by precipitating a transition metal N4-chelate precursor made of 50:50 molar percent H2 tetraphenyl porphyrin and cobalt tetraphenyl porphyrin onto plurality of removable template particles to produce dispersed precursor and pyrolyzing dispersed precursor to produce a pyropolymer
03/16/2010CA2512683C Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010028105A2 Amorphous pemetrexed disodium
03/11/2010WO2010027448A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
03/11/2010WO2010027431A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010WO2010027334A1 Novel tricyclic chiral compounds and their use in asymmetric catalysis
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026262A1 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
03/11/2010WO2010026214A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
03/11/2010WO2009140642A3 Tricyclic antagonists of prostaglandin d2 receptors
03/11/2010WO2009118411A3 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/11/2010WO2009026446A9 Hdac inhibitors
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063121 Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
03/11/2010US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
03/11/2010US20100063072 Solid forms of pemetrexed
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063054 cMET INHIBITORS
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 573